Previous studies demonstrated that PINK1/Parkin dependent mitophagy can facilitate chemotherapy resistance in ovarian cancer (32), hepatic carcinoma (33, 34), breast adenocarcinoma (35) and lung cancer (36). This evidence concerns the gene PRKN and hepatocellular carcinoma.